Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?

MeSH terms

• Humans
• Selective Serotonin Reuptake Inhibitors* / adverse effects
• Serotonin Agents
• Serotonin Syndrome* / chemically induced
• Serotonin Syndrome* / diagnosis
• Tryptamines / adverse effects
• United States
• United States Food and Drug Administration